Isolated Coronary Artery Bypass Graft Combined With Bone Marrow Mononuclear Cells Delivered Through a Graft Vessel for Patients With Previous Myocardial Infarction and Chronic Heart Failure: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Artery Bypass Graft ◽

Single Center ◽

Previous Myocardial Infarction ◽

Double Blind ◽

Isolated Coronary Artery Bypass Graft Combined With Bone Marrow Mononuclear Cells Delivered Through a Graft Vessel for Patients With Previous Myocardial Infarction and Chronic Heart Failure: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Yearbook of Cardiology ◽

10.1016/j.ycar.2012.01.007 ◽

2012 ◽

Vol 2012 ◽

pp. 273-275

Author(s):

B.J. Gersh

Keyword(s):

Mononuclear Cells ◽

Artery Bypass ◽

Bypass Graft ◽

Artery Bypass Graft ◽

Single Center ◽

Previous Myocardial Infarction ◽

Double Blind ◽

Isolated Coronary Artery Bypass Graft Combined With Bone Marrow Mononuclear Cells Delivered Through a Graft Vessel for Patients With Previous Myocardial Infarction and Chronic Heart Failure

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2011.01.037 ◽

2011 ◽

Vol 57 (24) ◽

pp. 2409-2415 ◽

Cited By ~ 60

Author(s):

Shengshou Hu ◽

Sheng Liu ◽

Zhe Zheng ◽

Xin Yuan ◽

Lihuan Li ◽

...

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Bone Marrow ◽

Coronary Artery ◽

Mononuclear Cells ◽

Artery Bypass ◽

Bypass Graft ◽

Artery Bypass Graft ◽

Previous Myocardial Infarction

Intravenous iron isomaltoside 1000 (Monofer ® ) reduces postoperative anaemia in preoperatively non‐anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double‐blind placebo‐controlled clinical trial (the PROTECT trial)

Vox Sanguinis ◽

10.1111/vox.12278 ◽

2015 ◽

Vol 109 (3) ◽

pp. 257-266 ◽

Cited By ~ 47

Author(s):

P. I. Johansson ◽

A. S. Rasmussen ◽

L. L. Thomsen

Keyword(s):

Clinical Trial ◽

Coronary Artery ◽

Artery Bypass ◽

Bypass Graft ◽

Intravenous Iron ◽

Artery Bypass Graft ◽

Double Blind ◽

Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group

JAMA ◽

10.1001/jama.275.9.687 ◽

1996 ◽

Vol 275 (9) ◽

pp. 687-692 ◽

Cited By ~ 21

Author(s):

E. Bennett-Guerrero

Keyword(s):

Coronary Artery ◽

Controlled Trial ◽

Artery Bypass ◽

Bypass Graft ◽

Cardiovascular Effects ◽

Study Group ◽

Artery Bypass Graft ◽

Double Blind ◽

A randomised, double-blind, placebo-controlled study of Glypromate® in patients undergoing coronary artery bypass graft surgery

http://isrctn.org/> ◽

10.1186/isrctn67437862 ◽

2012 ◽

Author(s):

Alan Merry

Keyword(s):

Coronary Artery ◽

Coronary Artery Bypass ◽

Artery Bypass ◽

Bypass Graft ◽

Controlled Study ◽

Artery Bypass Graft ◽

Double Blind ◽

Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial

Journal of Affective Disorders ◽

10.1016/j.jad.2015.04.049 ◽

2015 ◽

Vol 183 ◽

pp. 149-155 ◽

Cited By ~ 21

Author(s):

Seyed Hesameddin Abbasi ◽

Payam Mohammadinejad ◽

Nazila Shahmansouri ◽

Abbas Salehiomran ◽

Akram Arjmandi Beglar ◽

...

Keyword(s):

Coronary Artery ◽

Randomized Trial ◽

Coronary Artery Bypass ◽

Artery Bypass ◽

Bypass Graft ◽

Artery Bypass Graft ◽

Double Blind ◽

Double Blind Placebo ◽

Moderate Depression

Randomised, double-blind, placebo-controlled clinical trial for evaluating the efficacy of intracoronary injection of autologous bone marrow mononuclear cells in the improvement of the ventricular function in patients with idiopathic dilated myocardiopathy: a study protocol

BMC Cardiovascular Disorders ◽

10.1186/s12872-019-1182-4 ◽

2019 ◽

Vol 19 (1) ◽

Author(s):

Miguel Romero ◽

José Suárez-de-Lezo ◽

Concha Herrera ◽

Manuel Pan ◽

José López-Aguilera ◽

...

Keyword(s):

Clinical Trial ◽

Bone Marrow ◽

Ventricular Function ◽

Mononuclear Cells ◽

Autologous Bone Marrow ◽

Double Blind ◽

Double Blind Placebo ◽

Autologous Bone

Effects of autologous bone marrow mononuclear cells transplantation through coronary artery bypass grafting in patients with old myocardial infarction assessed by MRI: a randomised, double-blind, placebo-controlled pilot trial

Heart ◽

10.1136/heartjnl-2011-300867.401 ◽

2011 ◽

Vol 97 (Suppl 3) ◽

pp. A137-A138 ◽

Cited By ~ 1

Author(s):

L. Minjie ◽

Z. Shihua ◽

L. Sheng ◽

J. Shiliang ◽

Y. Gang

Keyword(s):

Mononuclear Cells ◽

Artery Bypass ◽

Pilot Trial ◽

Autologous Bone Marrow ◽

Bypass Grafting ◽

Double Blind ◽

Double Blind Placebo ◽

Old Myocardial Infarction ◽

Autologous Bone

The effects of dexmedetomidine infusion on renal functions after coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled study

Turkish Journal of Thoracic and Cardiovascular Surgery ◽

10.5606/tgkdc.dergisi.2013.7645 ◽

2013 ◽

Vol 21 (3) ◽

pp. 594-602 ◽

Cited By ~ 2

Author(s):

Deniz Göksedef

Keyword(s):

Coronary Artery ◽

Artery Bypass ◽

Bypass Graft ◽

Controlled Study ◽

Artery Bypass Graft ◽

Double Blind ◽

Double Blind Placebo ◽

Renal Functions ◽

Dexmedetomidine Infusion

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale

American Heart Journal ◽

10.1016/j.ahj.2008.01.002 ◽

2008 ◽

Vol 155 (4) ◽

pp. 600-608 ◽

Cited By ~ 3

Author(s):

Rajendra H. Mehta ◽

John H. Alexander ◽

Robert Emery ◽

Stephen J. Ellis ◽

Vic Hasselblad ◽

...

Keyword(s):

Coronary Artery ◽

Coronary Artery Bypass ◽

Artery Bypass ◽

Bypass Graft ◽

Artery Bypass Graft ◽

Double Blind ◽

Double Blind Placebo ◽

Cardioprotective Effects ◽

Surgery Trial